Merck KGaA (MKGAF)
Supplies labs and drugmakers with chemicals, equipment, and medicines for research and treatment.
$167.51+0.05%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+34.0%
The outlook
MKGAF trades at 167.51, sitting well above both its 50- and 200-day moving averages with strong upward momentum in its trend. The stock sits near the upper end of its 52-week range and carries a trailing P/E of 25.3, reflecting a premium valuation relative to recent earnings.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range86% of the way from its 52-week low to high
Market cap
$72.83B
52-wk high
$175.56
52-wk low
$116.68
50-day avg
$157.21
200-day avg
$143.41
Trailing P/E
25.3